ArticleDiscover oncology2026
Augmented reality navigation-assisted laparoscopic radical resection guided by the middle hepatic vein for giant hepatocellular carcinoma in the caudate lobe after neoadjuvant therapy.
Article in Discover oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Surgical resection is an effective treatment for malignant tumors in the caudate lobe of the liver. In view of the deep anatomical location of the caudate lobe and the complex adjacent structures, this operation has a high risk. In this case, we adopted a strategy of first neoadjuvant therapy to reduce the volume of the tumor, and then with the help of augmented reality navigation (ARN) technology, the middle hepatic vein (MHV) was used to guide the operation, and the tumor was finally successfully removed.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.